ZACCARO, LAURA
 Distribuzione geografica
Continente #
AS - Asia 28
EU - Europa 18
NA - Nord America 2
Totale 48
Nazione #
IT - Italia 17
CN - Cina 15
KR - Corea 10
SG - Singapore 2
US - Stati Uniti d'America 2
JP - Giappone 1
NL - Olanda 1
Totale 48
Città #
Naples 12
Seoul 10
Guangzhou 8
Amsterdam 1
Atena Lucana 1
Aversa 1
Boardman 1
Forest City 1
Tokyo 1
Totale 36
Nome #
A multi-targeting approach to fight sars-cov-2 attachment 8
Molecular interactions between a diphenyl scaffold and PED/PEA15: Implications for type II diabetes therapeutics targeting PED/PEA15 - Phospholipase D1 interaction 6
Novel and selective αvβ3 receptor peptide antagonist: Design, synthesis, and biological behavior 6
Screening a Molecular Fragment Library to Modulate the PED/PEA15-Phospholipase D1 Interaction in Cellular Lysate Environments 5
Isolation, Characterization and IgE Binding of Two 2S Albumins of Pomegranate Seeds 4
A new cryptic host defense peptide identified in human 11-hydroxysteroid dehydrogenase-1 ?-like: from in silico identification to experimental evidence 3
Deciphering RGDechi peptide-a5b1 integrin interaction mode in isolated cell membranes 3
Deciphering rgdechi peptide-?5?1integrin interaction mode in isolated cell membranes 2
A Combined NMR and Computational Approach to Determine the RGDechi-hCit-alpha(v)beta(3) Integrin Recognition Mode in Isolated Cell Membranes 2
AN IMPROVED RADIOLABELING SYNTHESIS OF RGDECHI WITH 18F-FLUORIDE. 2
Gold-Speckled SPION@SiO2 Nanoparticles Decorated with Thiocarbohydrates for ASGPR1 Targeting: Towards HCC Dual Mode Imaging Potential Applications 2
A synthetic peptide reproducing the mitochondrial targeting motif of AKAP121: A conformational study 1
Therapeutic Potential of a Novel alpha(v)beta(3) Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-Type 1
NIR Emitting Nanoprobes Based on Cyclic RGD Motif Conjugated PbS Quantum Dots for Integrin-Targeted Optical Bioimaging 1
Imaging of alpha(v)beta(3) Expression by a Bifunctional Chimeric RGD Peptide not Cross-Reacting with alpha(v)beta(5) 1
[99mTc][Tc(N)PNP43]-Labeled RGD Peptides As New Probes for a Selective Detection of alpha v beta (3) Integrin: Synthesis, Structure-Activity and Pharmacokinetic Studies. 1
Imaging of alpha(v)beta(3) Expression by a Bifunctional Chimeric RGD Peptide not Cross-Reacting with alpha(v)beta(5) 1
A new class of foldamers based on cis-gamma-amino-L-proline 1
Evaluation of the anti-angiogenic properties of the new selective alpha(V)beta(3) integrin antagonist RGDechiHCit 1
A novel approach for studying receptor-ligand interactions on living cells surface by using NUS/T1?-NMR methodologies combined with computational techniques: The RGDechi15D-?v?5 integrin complex 1
Chemical Modification for Proteolytic Stabilization of the Selective alpha(v)beta(3) Integrin RGDechi Peptide: in Vitro and in Vivo Activities on Malignant Melanoma Cells 1
A selective ?v?5 integrin antagonist hidden into the anophelin family protein cE5 from the malaria vector anopheles gambiae 1
HIGH YIELD HPLC PURIFICATION OF 18F-RDG-ECHI FOR INJECTION INTO MICE. 1
18FLUORO-ACTIVE-PEPTIDES: OPTIMIZATION OF RADIOLABELLING SYNTHESIS 1
Selective Detection of alfa_v beta_3 Integrin Receptors Using [99mTc(N)PNP]-labelled RGDechi Peptides 1
Gold Nanoparticles Capped by a GC-Containing Peptide Functionalized with an RGD Motif for Integrin Targeting. 1
A NEW AND SELECTIVE RADIOLABELED ALPHAVBETA3 PEPTIDE ANTAGONIST AS TRACER IN TUMOR DIAGNOSIS. 1
A new and selective radiolabeled áVâ3 peptide antagonist as tracer in tumor diagnosis 1
A new cryptic host defense peptide identified in human 11-hydroxysteroid dehydrogenase-1 ?-like: from in silico identification to experimental evidence 1
High-Resolution Conformational Analysis of RGDechi-Derived Peptides Based on a Combination of NMR Spectroscopy and MD Simulations 1
Conjugated Platinum(II)-peptide complexes for targeting integrin receptors 1
Totale 63
Categoria #
all - tutte 1.351
article - articoli 879
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.230


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202455 0 0 0 0 0 0 0 0 11 4 30 10
2024/20258 7 1 0 0 0 0 0 0 0 0 0 0
Totale 63